Roth Capital Reiterates Buy on SkinHealth Systems, Lowers Price Target to $2

Benzinga Newsdesk www.benzinga.com Negative 78.5%

Neg 78.5% Neu 0% Pos 0%

Roth Capital analyst George Kelly reiterates SkinHealth Systems (NASDAQ:SKIN) with a Buy and lowers the price target from $2.5 to $2.